Spectral AI, Inc.
corporate_fare Company Profile
Spectral AI, Inc. (NASDAQ:MDAI) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for MDAI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-09-15, rated 7/10. Across its 17 most recent items scored 7 or higher, the top rating is 9/10, with 11 rated 8 or above. Recent SEC coverage for MDAI spans 8-K, 10-Q, PRE 14A, 10-K.
Recent high-impact activity:
- Spectral AI Investor Deck Reveals $150M BARDA Contract and Commercial Launch Timeline
- Spectral AI Q2 2026: Cash Burn Accelerates, Material Weakness Persists Despite FDA Win
- Spectral AI Appoints Darcy Bajko as Chief Commercial Officer to Lead DeepView System Global Sales Launch
- Shareholders Approve Potential Highly Dilutive Share Issuance to Hudson Bay
- Spectral AI Receives FDA De Novo Classification for DeepView® System, Enabling Commercial Launch
Financial Snapshot
Short Interest & Short Volume
21.88 days to coverFINRA reported short interest of 2,195,305 shares in MDAI as of the September 15, 2026 settlement, a 1.8% decrease from the prior period — about 21.9 days to cover at its recent average daily volume. On October 2, 2026, 62.1% of MDAI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.